1. Fikree A, Byrne P. Management of functional gastrointestinal disorders. Clin Med (Lond). 2021;21(1):44-52. doi:10.7861/clinmed.2020-0980
2. Mukhtar K, Nawaz H, Abid S. Functional gastrointestinal disorders and gut-brain axis: What does the future hold?. World J Gastroenterol. 2019;25(5):552-566. doi:10.3748/wjg.v25.i5.552
3. Bousdouni P, Kandyliari A, Koutelidakis AE. Probiotics and Phytochemicals: Role on Gut Microbiota and Efficacy on Irritable Bowel Syndrome, Functional Dyspepsia, and Functional Constipation. Gastrointestinal Disorders. 2022; 4(1):30-48. https://doi.org/10.3390/gidisord4010005
4. Capozza M, Laforgia N, Rizzo V, et al. Probiotics and Functional Gastrointestinal Disorders in Pediatric Age: A Narrative Review. Front Pediatr. 2022;10:805466. Published 2022 Feb 16. doi:10.3389/fped.2022.805466
5. Holtmann G, Shah A, Morrison M. Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview. Dig Dis 2017;35(suppl 1):5-13. doi: 10.1159/000485409
6. The Rome Foundation. 2016. Rome IV Criteria. https://theromefoundation.org/rome-iv/rome-iv-criteria/
7. Siah KTH, Gong X, Yang XJ, et al. Rome Foundation-Asian working team report: Asian functional gastrointestinal disorder symptom clusters. Gut. 2018;67(6):1071-1077. doi:10.1136/gutjnl-2016-312852
8. Kerry RG, Patra JK, Gouda S, Park Y, Shin HS, Das G. Benefaction of probiotics for human health: A review. J Food Drug Anal. 2018;26(3):927-939. doi:10.1016/j.jfda.2018.01.002
9. Lewis ED, Antony JM, Crowley DC, Piano A, Bhardwaj R, Tompkins TA, Evans M. Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in Alleviating Symptoms of Irritable Bowel Syndrome (IBS): A Randomized, Placebo-Controlled Study. Nutrients. 2020; 12(4):1159. https://doi.org/10.3390/nu12041159
10. Wauters L, Slaets H, De Paepe K, et al. Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial [published correction appears in Lancet Gastroenterol Hepatol. 2021 Aug 27;. Lancet Gastroenterol Hepatol. 2021;6(10):784-792. doi:10.1016/S2468-1253(21)00226-0
11. Ibarra A, Latreille-Barbier M, Donazzolo Y, et al. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes. 2018;9(3):236-251. doi:10.1080/19490976.2017.1412908
12. Cheng J, Laitila A, Ouwehand AC. Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review. Front Nutr. 2021;8:790561. 2021 Dec 14. doi:10.3389/fnut.2021.790561
13. Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, Miller LE. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011 Sep;46(9):1057-64. doi: 10.3109/00365521.2011.584895. Epub 2011 Jun 13. PMID: 21663486; PMCID: PMC3171707.
14. Fauzi A, Makmun D, Maulahela H, Pribadi RR. Konsensus Nasional Perkumpulan Gastroenterologi Indonesia: Penatalaksanaan irritable bowel syndrome (IBS) dan dispepsia fungsional di Indonesia tahun 2021.
Facebook 
Masuk dengan Email
